The group’s principle activity is to provide software solutions to diagnose and monitor osteoporosis and osteoarthritis. The group's services include fracture risk assessment, and therapeutic monitoring of drug treatment. The group operates from United States.
Executive Information
Name
Title
Email
Patrick Hess
CEO, Pres.
N/A
Daniel Steines
Sr. VP - Research & Development
N/A
Claude Arnaud
Member - Scientific Advisory Board, Chief Medical Officer
